Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

18 December, 2025 | Thursday

OBI Pharma presents OBI-999 combo and Globo H-targeted CAR T-cell immunotherapy posters at AACR 2023

OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data demonstrating significant synergistic effects of OBI-999 and pembrolizumab (anti-PD1 mAb) in...

April 10, 2023 | Monday | News

1
2
3
4

Partner Content

Cytiva Launches Fibro dT Platform to Accelerate High-Yield mRNA Purification
07 November, 2025
Avance Clinical Launches CNS Center of Excellence to Advance Global Biotech Trials
29 October, 2025
GSK and Empirico Enter Exclusive Licensing Agreement for Novel siRNA Candidate EMP-012 in COPD
29 October, 2025
Catalent Introduces New Corporate Brand to Champion “Missions That Matter” Across Global Healthcare
29 October, 2025
Lonza Accelerates the Future of Pharma QC with Acquisition of Redberry and Its Breakthrough Red One™ Rapid Microbiology Platform
29 October, 2025
BD Showcases Next-Generation Drug Delivery and RFID Traceability Solutions at CPhI 2025
28 October, 2025

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2025 Biopharma Boardroom. All Rights Reserved.